Webinar Date/Time: Thu, Sep 28, 2023 11:00 AM EDT
Explore the complexities of upscaling the process from laboratory to clinical and commercial scales, while addressing the unique hurdles tied to producing ultra-fine particles (1-5µm) for effective lung delivery.
Register Free: https://www.pharmtech.com/pt_w/scale-up-considerations
Event Overview:
Spray drying is a versatile particle-engineering tool used to produce respirable dry powders of small molecule APIs and biologics. Production of very small particle sizes (1-5µm), is required for delivery to the deep lung, but also leads to significant challenges in scaling the process from lab-scale dryers to clinical or commercial scale dryers. This webinar addresses the scale-up challenges facing pulmonary dry powders produced by spray drying.
Key Learning Objectives
Who Should Attend
Speakers
Kim Shepard
Associate Director, Principal Engineer, R&D
Lonza Small Molecules
Kim Shepard is a Principal Engineer in the Research group at Lonza's site in Bend, Oregon, USA, where she has worked since 2015. She leads projects focused on developing new technologies for bioavailability enhancement and inhalation delivery. Kim’s areas of expertise include the formulation and manufacturing of spray-dried dispersions for inhalation and oral delivery, as well as the physics of polymers and amorphous materials. She received her Bachelor and Master's degrees in Chemical Engineering from Stevens Institute of Technology and her Ph.D. in Chemical Engineering from Princeton University.
Cody Prather
Sr. Engineer, Research & Development
Lonza Small Molecules
Cody Prather is a Sr. Engineer in the R&D group at Lonza at the Bend, Oregon site, having worked there since 2015. He obtained his Master’s degree in Mechanical Engineering at Montana State University. His focus has been on generating innovative solutions in engineering design and atomization technologies as related to some of Lonza’s key platforms: bioavailability enhancement, multiparticulates, and inhalation. He currently leads the engineering endeavors of the R&D inhalation platform.
Register Free: https://www.pharmtech.com/pt_w/scale-up-considerations
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.